D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability
Cerebrovascular Diseases Extra · 2023
DOI: 10.1159/000535644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebrovascular Diseases Extra, 2023. Verfasst von Jun Fujinami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan, jun2473@gmail.com. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke, Thrombophilia, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
In patients with cancer-associated hypercoagulability (CAH)-related stroke, D-dimer trends after anticoagulant therapy may offer a biomarker of treatment efficacy. The purpose of this study was to clarify the association between D-dimer trends and recurrent stroke after anticoagulant therapy in patients with CAH-related stroke.
Methods
We performed retrospective cohort study of consecutive patients with CAH-related stroke at two stroke centers from 2011 to 2020. The ratio of posttreatment to pretreatment D-dimer levels (post/pre ratio) was used as an indicator of D-dimer trends after anticoagulant therapy. Fine-Gray models were used to evaluate the association between post/pre ratio and recurrent stroke.
Results
Among 360 acute ischemic stroke patients with active cancer, 73 patients with CAH-related stroke were included in this study. Recurrent stroke occurred in 13 patients (18%) during a median follow-up time of 28 days (interquartile range, 11–65 days). Multivariate analysis revealed that high post/pre ratio was independently associated with recurrent stroke (per 0.1 increase: hazard ratio 2.20, 95% confidence interval 1.61–3.01, p = 0.012).
Conclusion
D-dimer levels after anticoagulant therapy were associated with recurrent stroke in CAH-related stroke patients. Patients with neutral trends in high D-dimer levels after anticoagulant therapy were at high risk of recurrent stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan, jun2473@gmail.com.
- Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
- Department of Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Zitieren
APA
Fujinami, J., Nagakane, Y., Fujikawa, K., Murata, S., Maezono, K., Ohara, T., & Mizuno, T. (2023). D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability. Cerebrovascular Diseases Extra. https://doi.org/10.1159/000535644
Vancouver
Fujinami J, Nagakane Y, Fujikawa K, Murata S, Maezono K, Ohara T, et al. D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability. Cerebrovascular Diseases Extra. 2023. doi:10.1159/000535644
BibTeX
@article{Fujinami2023,
author = {Fujinami, Jun and Nagakane, Yoshinari and Fujikawa, Kei and Murata, Shohei and Maezono, Keiko and Ohara, Tomoyuki and Mizuno, Toshiki},
title = {D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability},
journal = {Cerebrovascular Diseases Extra},
year = {2023},
doi = {10.1159/000535644}
}
EUVIMED